Filing Details

Accession Number:
0001140361-13-043177
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-15 16:56:13
Reporting Period:
2013-11-13
Filing Date:
2013-11-15
Accepted Time:
2013-11-15 16:56:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
70487 National Research Corp NRCIA/B Services-Commercial Physical & Biological Research (8731) 470634000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1248110 N John Nunnelly P.o. Box 2175
Amherst MA 01004
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class B Common Stock Acquisiton 2013-11-13 1,697 $16.18 5,597 No 4 M Direct
Class B Common Stock Disposition 2013-11-13 1,697 $33.64 3,900 No 4 S Direct
Class B Common Stock Acquisiton 2013-11-14 108 $16.18 4,008 No 4 M Direct
Class B Common Stock Disposition 2013-11-14 108 $33.50 3,900 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class B Common Stock Director Stock Option (Right to Buy) Disposition 2013-11-13 1,697 $0.00 1,697 $16.18
Class B Common Stock Director Stock Option (Right to Buy) Disposition 2013-11-14 108 $0.00 108 $16.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,303 2008-05-03 2017-05-03 No 4 M Direct
4,195 2008-05-03 2017-05-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 23,400 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Class A Common Stock Director Stock Option (Right to Buy) $7.20 2008-05-03 2017-05-03 36,000 36,000 Direct
Class A Common Stock Director Stock Option (Right to Buy) $8.49 2009-05-02 2018-05-02 36,000 36,000 Direct
Class A Common Stock Director Stock Option (Right to Buy) $7.78 2010-05-08 2019-05-08 36,000 36,000 Direct
Class A Common Stock Director Stock Option (Right to Buy) $7.61 2011-05-07 2020-05-07 36,000 36,000 Direct
Class A Common Stock Director Stock Option (Right to Buy) $9.73 2012-05-06 2021-05-06 36,000 36,000 Direct
Class A Common Stock Director Stock Option (Right to Buy) $13.81 2013-05-11 2022-05-11 36,000 36,000 Direct
Class A Common Stock Director Stock Option (Right to Buy) $16.89 2014-05-09 2023-05-09 36,000 36,000 Direct
Class B Common Stock Director Stock Option (Right to Buy) $18.11 2009-05-02 2018-05-02 6,000 6,000 Direct
Class B Common Stock Director Stock Option (Right to Buy) $17.06 2010-05-08 2019-05-08 6,000 6,000 Direct
Class B Common Stock Director Stock Option (Right to Buy) $16.80 2011-05-07 2020-05-07 6,000 6,000 Direct
Class B Common Stock Director Stock Option (Right to Buy) $19.98 2012-05-06 2021-05-06 6,000 6,000 Direct
Class B Common Stock Director Stock Option (Right to Buy) $26.10 2013-05-11 2022-05-11 6,000 6,000 Direct
Class B Common Stock Director Stock Option (Right to Buy) $30.72 2014-05-09 2023-05-09 6,000 6,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-05-03 36,000 36,000 Direct
2018-05-02 36,000 36,000 Direct
2019-05-08 36,000 36,000 Direct
2020-05-07 36,000 36,000 Direct
2021-05-06 36,000 36,000 Direct
2022-05-11 36,000 36,000 Direct
2023-05-09 36,000 36,000 Direct
2018-05-02 6,000 6,000 Direct
2019-05-08 6,000 6,000 Direct
2020-05-07 6,000 6,000 Direct
2021-05-06 6,000 6,000 Direct
2022-05-11 6,000 6,000 Direct
2023-05-09 6,000 6,000 Direct
Footnotes
  1. On May 22, 2013, the Issuer completed a recapitalization pursuant to which it, among other things, issued a stock dividend of three shares of class A common stock for each share of then-existing common stock and reclassified each share of its then-existing common stock as one-half of one share of class B common stock. All fractional shares of class B common stock were cashed-out in the recapitalization. In connection with the recapitalization, the exercise prices of outstanding options were equitably adjusted to prevent the dilution or enlargement of the benefits intended to be provided.
  2. The price in Column 4 is a weighted average price. The prices actually received ranged from $33.50 to $34.01. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.